Environmental laboratory
Test Medical Cannabis Potency with Greater Accuracy Using New DEA-Exempted CBDA Certified Reference Material
Jan 16 2017
As part of our commitment to the emerging industry of medical cannabis analysis, Restek has expanded its selection of cannabinoid-related reference standards by adding cannabidiolic acid (CBDA). This 1,000 ppm standard is DEA-exempted, so there’s no need to purchase costly neat materials or to make your own standards, and it is prepared in acetonitrile, which helps maintain stability by preventing methylation of the carboxylic acid group on the molecule. Paired with Restek’s THC standards, it is perfect for the analysis of both neutrals and acids in cannabis products by LC and is a must for accurate quantification in medical cannabis potency testing and strain ID. Restek’s CBDA standard is also a certified reference material (CRM) so you know that it meets strict ISO quality requirements.
From potency to pesticides analysis, Restek offers the LC and GC chromatography columns, CRMs, accessories, and sample prep supplies—as well as technical literature and support—needed for accurate, reliable medical marijuana analysis. Learn more about Restek’s products and resources at www.restek.com/medical-cannabis and start growing your medical cannabis testing business today.
Digital Edition
AET Guide 2025
March 2025
Buyer's Guide Directory - Product Listings by Category - Suppliers Listings (A-Z) Air Monitoring - Stack Emissions Multi-Gas Analysis: OFCEAS<sup>®</sup> Technology Seduces the Market...
View all digital editions
Events
Mar 19 2025 Manila, Philippines
Mar 19 2025 New Delhi, India
Mar 20 2025 Guangzhou, China
Mar 25 2025 Las Vegas, NV, USA
Mar 25 2025 Lyon, France